Scientists uncover hidden electrical switch that fuels colorectal Cancer's spread

NCT ID NCT07650786

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates how differences in cell membrane voltage, caused by varying physical pressures inside a tumor, help colorectal cancer resist chemotherapy and evade the immune system. Using advanced lab models and tissue samples from 11 patients, researchers found that cells at the tumor's edge are electrically active and aggressive, while core cells are suppressed but stress-adapted. The work identifies a key immune checkpoint, PVR/CD96, that could be targeted to restore immune attack. This is a basic science study, not a treatment trial, but it may guide future drug development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If the findings hold, this could point toward new treatments that target membrane potential or the PVR/CD96 immune checkpoint to overcome drug resistance and improve immunotherapy in colorectal cancer.

What could go wrong

This is a very early, small study with only 4 participants and relies heavily on lab models. The results may not translate to real-world patients, and any potential therapies are years away from being tested in people.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nanagngqu

    Harbin, China